Helius Medical Technologies, Inc. (HSDT)

2.8700 +0.2100 (+7.89%) At close: 04:00PM EDT

Helius Medical Technologies, Inc.

642 Newtown Yardley Road
Suite 100
Newtown, PA 18940
United States
215 944 6100
https://heliusmedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 22

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Dane Carl Andreeff	President, CEO & Director	519.76k	N/A	1966
Dr. Antonella Favit-Van Pelt M.D., Ph.D.	Chief Medical Officer	471.56k	N/A	1967
Mr. Lawrence Picciano	Senior Vice President of Engineering, Quality & Regulatory Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Corporate governance

Helius Medical Technologies, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.